Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcel Hoogenraad

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Current Opinion in Drug Discovery & Development|February 5, 2004
Advances in multivariate analysis in pharmaceutical process developmentBen McKay, Marcel Hoogenraad, Eric W Damen, et al.
Steroids|March 4, 2008
A highly selective method for 11 beta-OH protection of steroidal 11 beta, 17 alpha-diolsPaul A Glossop, Marcel Hoogenraad, Torren M Peakman, et al.
Acta Crystallographica. Section C, Crystal Structure Communications|July 3, 2002
Tris[2-(2-oxazolin-2-yl)phenolato]iron(III)Huub Kooijman, Anthony L Spek, Marcel Hoogenraad, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Current Opinion in Drug Discovery & Development|February 5, 2004
Advances in multivariate analysis in pharmaceutical process developmentBen McKay, Marcel Hoogenraad, Eric W Damen, et al.
Steroids|March 4, 2008
A highly selective method for 11 beta-OH protection of steroidal 11 beta, 17 alpha-diolsPaul A Glossop, Marcel Hoogenraad, Torren M Peakman, et al.
Acta Crystallographica. Section C, Crystal Structure Communications|July 3, 2002
Tris[2-(2-oxazolin-2-yl)phenolato]iron(III)Huub Kooijman, Anthony L Spek, Marcel Hoogenraad, et al.
Pageof 1